XOMA Royalty Corp

XOMAO is the ticker symbol for XOMA Royalty Corp, a publicly traded US company.

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.

Key metrics include a return on equity of 4.8%, a debt-to-equity ratio of 1.71.

The company reports trailing twelve-month revenue of $12.32M and net income of $4.46M.

FINOTAUR aggregates real-time and fundamental data on XOMAO to help traders and investors make informed decisions. Track XOMAO in your trading journal alongside other positions for a unified view of your portfolio.